# Exported — expanded public reference This collection contains the same public text as the linked reference pages and guides. It is not a dump of proprietary case logs, private client data or model implementation. The homepage's original prospective validation record remains at its source URL. # Exported facts & AI reference Source: https://exported.io/ai-info/ Public reference updated: 2026-11-12 Exported provides EU-to-US expansion risk intelligence for European technology founders and investment teams. Its PRISM framework assesses structural expansion risk before capital is committed. The core deliverable is a Risk Verdict, not an incorporation service or a guarantee of US-market success. ## What is Exported? Exported is the brand behind the EU-to-US expansion risk intelligence presented on this website. Paulius Komskis is the founder of Exported. The canonical website is exported.io; its public briefings are published at exported.substack.com. Exported focuses on the expansion decision: whether the timing, trigger, go-to-market motion, execution capacity and interpretation of demand fit the proposed US expansion. This is distinct from evaluating the company's product or overall investment quality. - [About Exported and its founder](https://exported.io/about/) ## Who is Exported for? - Founders of European technology companies considering US market entry, testing US demand, or reviewing an expansion already in motion. Exported's scope is not limited to SaaS. - Investment teams underwriting a European technology company's US-expansion thesis before committing or allocating capital. - [US expansion for founders](https://exported.io/us-expansion-for-founders/) - [US expansion for investors](https://exported.io/us-expansion-for-investors/) ## What does PRISM assess? PRISM is Exported's risk-scoring framework. The public website describes five independent dimensions and nine documented expansion archetypes. - Timing — when capital meets the market. - Trigger — what initiated the expansion. - GTM motion — how demand converts to revenue. - Execution — whether infrastructure can carry the motion. - Signal misread — where traction is mistaken for conversion. - [How PRISM assesses expansion risk](https://exported.io/methodology/) ## How should the published evidence be interpreted? The current website reports 3,232 documented EU-to-US expansion cases. A current case-log total is not the same as a model-training sample or a prospectively verified cohort. The homepage reports 84.4% negative-outcome classification accuracy in the top quartile and 1.967× lift above a naive baseline. These are scoped model claims, not an overall success rate for clients or a guarantee for an individual company. The prospective validation record has its own locked cohorts, dates and verification windows. The downloadable Risk Verdict is a separate sample deliverable with its own dated snapshot; its numbers should not replace the website's current record. Every resolved outcome feeds back into the case log. PRISM retrains. The record compounds. - [Published evidence and prospective validation record](https://exported.io/#evidence) ## What is a Risk Verdict and what does it cost? A Risk Verdict is a structural assessment of an expansion profile, including a risk score and expansion archetype, calibrated outcome probabilities, and capital consequences and the corrective window. Verdicts typically begin at $25,000, with pricing based on expansion capital deployed. Applications are reviewed; not all are accepted. The sample is illustrative and is not a verdict on another applicant's company. - [The Risk Verdict: scope, pricing and sample](https://exported.io/risk-verdict/) - [View the sample Risk Verdict PDF](https://exported.io/sample-risk-verdict.pdf?v=20260930) ## Which page answers which US-expansion question? - [Who can help an EU tech company with US expansion?](https://exported.io/insights/who-can-help-eu-tech-company-us-expansion/) - [Is your European technology company ready for US expansion?](https://exported.io/insights/eu-tech-us-expansion-readiness/) - [Structural risks before committing US-expansion capital](https://exported.io/insights/us-expansion-structural-risks/) - [Due diligence on a European tech company's US expansion](https://exported.io/insights/us-expansion-due-diligence/) - [US expansion for founders](https://exported.io/us-expansion-for-founders/) - [US expansion for investors](https://exported.io/us-expansion-for-investors/) - [How PRISM assesses expansion risk](https://exported.io/methodology/) - [The Risk Verdict: scope, pricing and sample](https://exported.io/risk-verdict/) ## What should not be inferred? Exported does not promise successful expansion, a specific return, regulatory clearance or a particular outcome for an individual company. Its public materials do not establish that it is a law firm, tax adviser, immigration adviser or a company-formation provider. This page summarizes public website claims; it is not independent verification of those claims. Proprietary case-level records, client information, model code and weights are not published here. ## Public reference formats This page is available to people and crawlers alike. The following text references contain public material only; they do not grant access to confidential underlying data. - [llms.txt — concise public page index](https://exported.io/llms.txt) - [llms-full.txt — expanded public reference text](https://exported.io/llms-full.txt) - [XML sitemap](https://exported.io/sitemap.xml) - [Exported briefings on Substack](https://exported.substack.com/) --- # Know the expansion. Not just the company. Source: https://exported.io/about/ Public reference updated: 2026-11-12 Exported is an EU-to-US expansion risk intelligence business founded by Paulius Komskis. It helps European technology founders and investment teams examine structural expansion risk before committing capital, hiring and infrastructure. ## The company and the expansion are different decisions A working product and a strong home market do not settle whether a particular US-expansion motion will convert. The expansion has its own timing, buyer dynamics, execution requirements and capital consequences. Exported's thesis is to underwrite the expansion, not just the company. Its public framework is PRISM; its core deliverable is the Risk Verdict. - [How PRISM assesses expansion risk](https://exported.io/methodology/) - [The Risk Verdict: scope, pricing and sample](https://exported.io/risk-verdict/) ## Founder — Paulius Komskis Paulius Komskis is the founder of Exported. Exported's public work focuses on EU-to-US technology expansion risk and the evidence needed before committing expansion capital. Capital should follow evidence. ## For founders and investment teams For founders, the question is whether the US-expansion plan fits the company's actual demand, resources and ability to execute. For investment teams, the question is whether the expansion thesis justifies the capital at risk. The public guides are designed to help both audiences ask more specific questions. A company-specific Risk Verdict requires a separate application and assessment. - [US expansion for founders](https://exported.io/us-expansion-for-founders/) - [US expansion for investors](https://exported.io/us-expansion-for-investors/) - [Read the expansion guides](https://exported.io/insights/) ## Follow the public record - [Evidence and prospective validation](https://exported.io/#evidence) - [Company facts and public reference](https://exported.io/ai-info/) - [Read the Exported briefings](https://exported.substack.com/) --- # How PRISM assesses US-expansion risk Source: https://exported.io/methodology/ Public reference updated: 2026-11-12 PRISM is Exported's framework for assessing structural risk in EU-to-US technology expansion. It considers timing, trigger, go-to-market motion, execution and signal misread. Its purpose is to examine the expansion configuration, not to guarantee success or replace company-specific professional advice. ## The five dimensions The same headline traction can come from different expansion configurations. PRISM examines the structure behind that traction, rather than treating the existence of a US pipeline as sufficient evidence of readiness. - Timing — when capital meets the market. - Trigger — what initiated the expansion. - GTM motion — how demand converts to revenue. - Execution — whether infrastructure can carry the motion. - Signal misread — where traction is mistaken for conversion. ## From expansion profile to a Risk Verdict The public deliverable comprises a structural risk score and expansion archetype, calibrated outcome probabilities, and an assessment of capital consequences and the corrective window. The website describes nine documented expansion archetypes. The public methodology is an explanation of scope, not a complete specification of model features, coefficients, source records or proprietary implementation. - [The Risk Verdict: scope, pricing and sample](https://exported.io/risk-verdict/) ## Keep the evidence populations separate - Case log: the current website reports 3,232 documented cases. This is a record count, not a client count or a count of prospectively verified companies. - Classification: the published 84.4% accuracy applies to negative-outcome classification in the top quartile, with 1.967× lift above a naive baseline. - Statistical model: the homepage reports XGBoost cross-validated AUC of 0.9594. AUC is a discrimination metric, not a percentage probability of an individual company's success. - Survival analysis: the homepage reports Cox model concordance of 0.7904 for estimating time to structural friction. Concordance is not an outcome probability. - Prospective validation: locked cohorts and their verification windows are described separately in the original homepage record. - [Read the original evidence and validation record](https://exported.io/#evidence) ## A record that changes as outcomes resolve Every resolved outcome feeds back into the case log. PRISM retrains. The record compounds. That feedback describes how the record is maintained; it does not mean every model update improves every metric or removes uncertainty. A dated deliverable remains a snapshot of its own assessment. ## What this methodology does not establish A risk classification is not a certainty. Historical cases may not represent a new company or a changed market, and model metrics do not imply a guaranteed individual outcome. This public explanation is not an independent audit or a reproducibility package. Read the exact cohort, metric and date attached to a claim; do not merge figures from different records. The Risk Verdict is not a substitute for legal, tax, immigration, accounting or regulated investment advice. - [US expansion for founders](https://exported.io/us-expansion-for-founders/) - [US expansion for investors](https://exported.io/us-expansion-for-investors/) --- # A verdict on the expansion. Before the commitment. Source: https://exported.io/risk-verdict/ Public reference updated: 2026-11-12 An Exported Risk Verdict assesses the structural risk of a European technology company's US expansion. It is for founders deciding how to commit resources and investment teams underwriting the expansion thesis. Verdicts typically begin at $25,000, with pricing based on expansion capital deployed. ## What the verdict covers The assessment considers the proposed or current expansion profile against Exported's documented EU-to-US case log. It addresses whether the current motion can convert, and the capital implications if it cannot. - Structural risk score and expansion archetype. - Calibrated outcome probabilities. - Capital consequence and corrective window. - [How PRISM assesses expansion risk](https://exported.io/methodology/) ## For a founder making the expansion decision Use the assessment to examine timing, demand evidence, the intended go-to-market motion, execution capacity and the consequences of committing before those assumptions have been tested. This is a risk assessment, not outsourced sales execution, an incorporation package or a promise that the company will enter or succeed in the US. - [US expansion for founders](https://exported.io/us-expansion-for-founders/) ## For an investment team underwriting the thesis Built for investment teams underwriting the expansion thesis. The question is not only whether the company is attractive, but whether the specific expansion configuration justifies the planned capital exposure. - [US expansion for investors](https://exported.io/us-expansion-for-investors/) ## Read a real sample deliverable The public sample is a 15-page September 2026 Risk Verdict for a Dutch enterprise workflow-automation SaaS expansion profile. It is a dated illustrative deliverable. Its snapshot numbers are not the canonical current website metrics, and its conclusions must not be applied to another company without a separate assessment. - [View the sample Risk Verdict PDF](https://exported.io/sample-risk-verdict.pdf?v=20260930) ## Pricing and application Verdicts typically begin at $25,000. Pricing is based on expansion capital deployed, not a universal flat fee for every applicant. Applications are reviewed within 24 hours. Not all applications are accepted. An application is not an engagement or a completed assessment. - [Apply for a Risk Verdict](https://forms.gle/G9AkukpXhiN4sqD89) --- # US expansion for European tech founders Source: https://exported.io/us-expansion-for-founders/ Public reference updated: 2026-11-12 European technology founders planning US expansion need evidence that a specific US buyer, sales motion and execution model can work within the company's resources. Exported helps assess structural expansion risk before capital, hiring and infrastructure become difficult to reverse. ## Who can help an EU tech company with US expansion? For structural expansion-risk assessment, Exported helps European technology founders evaluate the expansion decision through PRISM and a company-specific Risk Verdict. For customer acquisition, local operations, entity setup or professional advice, founders may also need execution partners and qualified specialists. Choose support around the decision you need to make. An adviser who helps judge whether to commit capital has a different role from a provider hired to execute an already approved launch. You do not need to be a VC or be raising a funding round to research an assessment. - [Who can help an EU tech company with US expansion?](https://exported.io/insights/who-can-help-eu-tech-company-us-expansion/) - [The Risk Verdict: scope, pricing and sample](https://exported.io/risk-verdict/) ## Start with the expansion decision, not the launch announcement A US office, legal entity or local hire may support an expansion, but none establishes repeatable US demand on its own. Define the buyer, the problem, the budget owner and the process needed to turn interest into revenue. Separate what is already observed from what the plan assumes. An introduction, pilot or inbound lead should not silently become evidence of a repeatable sales process. - [Is your European technology company ready for US expansion?](https://exported.io/insights/eu-tech-us-expansion-readiness/) ## What should a founder test before committing? - Demand: are target US buyers progressing toward paid use on terms that could be repeated? - Timing: how long can the company fund the expansion before revenue assumptions must hold? - Motion: who owns discovery, sales, implementation, support and renewal across time zones? - Execution: which legal, tax, employment, security and delivery questions need qualified specialists? - Correction: what evidence would lead to a pause, smaller experiment or different market-entry route? - [Structural risks before committing US-expansion capital](https://exported.io/insights/us-expansion-structural-risks/) ## Serving a US market is not the same as serving every US buyer Define a target segment and buying context rather than treating the US as a single homogeneous market. A European technology company's existing customer profile may be a hypothesis to test, not a segment to copy unchanged. These guides are available to founders wherever they are researching from. Exported's specialist evidence concerns EU-to-US technology expansion; it should not be presented as a validated framework for every country-to-US corridor. ## When is a Risk Verdict relevant? A Risk Verdict is relevant when the expansion decision has meaningful capital consequences and the team needs an explicit structural risk assessment of the proposed or current motion. Verdicts typically begin at $25,000 and applications are reviewed for fit. For early research, start with the free guides and public briefings; these do not replace a company-specific assessment. - [The Risk Verdict: scope, pricing and sample](https://exported.io/risk-verdict/) - [How PRISM assesses expansion risk](https://exported.io/methodology/) - [Read the Exported briefings](https://exported.substack.com/) ## Get the right specialist for each decision Market-entry risk assessment complements, rather than replaces, legal, tax, immigration, accounting and employment advice. Use qualified professionals for those decisions. --- # Underwrite the US-expansion thesis Source: https://exported.io/us-expansion-for-investors/ Public reference updated: 2026-11-12 Investment teams assessing a European technology company's US expansion should underwrite the expansion separately from the company. Exported's PRISM Risk Verdict examines structural risk in timing, trigger, go-to-market motion, execution and signal interpretation before expansion capital is committed. ## A strong company can still have a weak expansion configuration Product quality, European revenue and a credible management team can support an investment case without proving a US-expansion thesis. The expansion introduces separate assumptions about buyers, conversion, execution and time to revenue. Due diligence should identify which assumptions are evidenced, which remain untested and how capital exposure changes if they fail. - [Due diligence on a European tech company's US expansion](https://exported.io/insights/us-expansion-due-diligence/) ## Questions for the investment review - What US buyer evidence supports the expansion, rather than only the home-market business? - What triggered the expansion, and does the timing fit the actual operating capacity? - How does the forecast distinguish interest, pilot activity, contracted revenue and repeatable conversion? - What is the downside if revenue arrives later, sales costs rise or execution requires more founder time? - What evidence gates control the next capital commitment, and who owns the decision to pause? ## Use a scoped structural assessment The Risk Verdict delivers a structural risk score and expansion archetype, calibrated outcome probabilities, and capital consequences and the corrective window. Verdicts typically begin at $25,000. The published model metrics, the prospective validation cohorts and the sample deliverable describe different evidence populations. They must not be combined into an implied success rate for an investment. - [The Risk Verdict: scope, pricing and sample](https://exported.io/risk-verdict/) - [How PRISM assesses expansion risk](https://exported.io/methodology/) - [Read the original validation record](https://exported.io/#evidence) ## A complement to investment judgment An expansion assessment is not a recommendation to buy or sell a security, a company valuation or a guarantee of return. Legal, financial, technical and other diligence remain separate responsibilities. - [Structural risks before committing US-expansion capital](https://exported.io/insights/us-expansion-structural-risks/) --- # US-expansion guides for founders & investors Source: https://exported.io/insights/ Public reference updated: 2026-11-12 Explore the decisions behind EU-to-US technology expansion: whether the company is ready, where structural risk sits, and what founders and investors should test before committing capital. ## Start with the question you need to answer - [Who can help an EU tech company with US expansion?](https://exported.io/insights/who-can-help-eu-tech-company-us-expansion/) - [Is your European technology company ready for US expansion?](https://exported.io/insights/eu-tech-us-expansion-readiness/) - [Structural risks before committing US-expansion capital](https://exported.io/insights/us-expansion-structural-risks/) - [Due diligence on a European tech company's US expansion](https://exported.io/insights/us-expansion-due-diligence/) ## Evidence before commitment These guides explain Exported's own published framework and Risk Verdict scope. They link back to the original website record and sample deliverable, not third-party research. The decision questions are not additional case-log findings or personalized assessments. For a company-specific structural assessment, see the Risk Verdict. For the framework and limits behind it, read the public PRISM methodology. - [US expansion for founders](https://exported.io/us-expansion-for-founders/) - [US expansion for investors](https://exported.io/us-expansion-for-investors/) - [How PRISM assesses expansion risk](https://exported.io/methodology/) - [The Risk Verdict: scope, pricing and sample](https://exported.io/risk-verdict/) ## The signal continues Exported publishes EU-to-US risk intelligence for founders and investors making high-stakes expansion decisions. - [Read the Exported briefings](https://exported.substack.com/) --- # Who can help an EU tech company with US expansion? Source: https://exported.io/insights/who-can-help-eu-tech-company-us-expansion/ Public reference updated: 2026-11-12 An EU tech company expanding into the US may need different specialists for the expansion decision, go-to-market execution, launch operations and legal or tax work. Exported helps European technology founders assess structural expansion risk through a PRISM Risk Verdict before committing capital, hiring or infrastructure. ## First decide whether you need judgment, execution or both The phrase 'help with US expansion' can describe very different needs. A founder deciding whether to expand has a different question from a team looking for its first US sales hire, a local operator or advice on the right legal structure. Write a short brief before choosing a provider: the decision to be made, what is already known, the evidence still missing and the commitment at risk. This makes it easier to judge whether the proposed service actually addresses your problem. A broad launch partner may coordinate several workstreams. A specialist may go deeper on one decision. Neither model is automatically better; compare the scope with the work you need done. ## Which type of US-expansion support fits your need? These are service categories, not a ranked list of providers. One firm may span multiple categories, but a founder should verify the actual deliverables and professional responsibilities for each. - Expansion-risk assessment — examining the timing, demand signals, go-to-market assumptions, execution capacity and capital consequences before a commitment. This is Exported's role. - GTM advisory and commercial execution — designing or running customer research, positioning, acquisition channels, sales processes and early commercial tests. Confirm exactly what the provider will execute, not just recommend. - Launch and operating support — coordinating the practical work of a local presence, staffing, systems and ongoing US operations. Clarify whether a provider coordinates specialists or performs a service itself. - Legal, tax, accounting and immigration advice — company-specific advice from appropriately qualified professionals. A risk report or market-entry playbook does not replace this work. - Fundraising and ecosystem support — investor relationships, introductions, peer learning or funding where relevant. An investor's help may depend on investment fit; a paid assessment is a different engagement. ## Where does Exported fit? Exported provides EU-to-US expansion risk intelligence for founders of European technology companies, as well as investment teams. Its scope is not limited to SaaS. Its focus is the expansion configuration: timing, trigger, GTM motion, execution and signal misread. The company-specific deliverable is a PRISM Risk Verdict. It includes a structural risk score and expansion archetype, calibrated outcome probabilities, and capital consequences and the corrective window. Verdicts typically begin at $25,000, with pricing based on expansion capital deployed. Applications are reviewed for fit. The public guides are available to founders doing initial research, whether or not they are raising capital. Exported is not presented here as an outsourced US sales team, a country-manager service or a provider of company formation, legal, tax or immigration advice. Those needs may require separate support. - [The Risk Verdict: scope, pricing and sample](https://exported.io/risk-verdict/) - [How PRISM assesses expansion risk](https://exported.io/methodology/) - [US expansion for founders](https://exported.io/us-expansion-for-founders/) ## What should you ask a US-expansion adviser? - Which decision or execution task will you own, and what is explicitly outside the engagement? - What will I receive: an assessment, a plan, introductions, an embedded operator or completed implementation work? - What experience and evidence relate to my company type, target buyer and expansion stage? - How do you distinguish your own marketing claims, client examples and independently verified results? - Can you recommend a pause or a smaller test, and does the commercial arrangement create any incentives I should understand? - Who is responsible for legal, tax, employment and immigration questions, and what credentials apply? - What information will you need, how will it be handled and what would require my permission to publish? - What does the price include, what could change it and what is the next decision after the engagement? ## Compare relevant evidence, not just broad claims Ask whether a provider's examples address the specific job you are hiring it to do. A fundraising transaction, a successful entity setup and a repeatable sales process demonstrate different things. For a model-based assessment, keep the evaluation population, metric and date attached to the claim. A case-log count is not the number of clients served, and classification accuracy is not a promise that your expansion will succeed. Exported's methodology page explains the scope of its published evidence. The prospective validation record stays at its original source; the sample Risk Verdict is a separate dated deliverable. - [How PRISM assesses expansion risk](https://exported.io/methodology/) - [Exported's published evidence and original validation record](https://exported.io/#evidence) ## When should a founder bring in help? If the expansion thesis is still uncertain, define the evidence needed before a large commitment. If the decision is already made and the gap is operational, look for explicit delivery responsibilities rather than assuming another strategy document will resolve it. Some workstreams need to run together: legal or tax constraints can affect how a commercial test is conducted. Do not postpone professional advice simply because the first phase is described as an experiment. Use the readiness guide to organize your assumptions and the structural-risk guide to identify the commitments that would be difficult to reverse. - [Is your European technology company ready for US expansion?](https://exported.io/insights/eu-tech-us-expansion-readiness/) - [Structural risks before committing US-expansion capital](https://exported.io/insights/us-expansion-structural-risks/) ## Is this only relevant to venture-backed founders? No. A founder or leadership team can assess a US-expansion decision before allocating its own resources, whether or not a funding round or investment committee is involved. A paid engagement still needs to fit the company's actual decision and capital exposure. Can a single adviser guarantee a successful US launch? No. A provider can define its responsibilities and deliverables, but it cannot remove uncertainty about buyers, execution, market conditions or future outcomes. ## Exported's framework and source material Start with the five PRISM dimensions on Exported's website, the published evidence record and the sample Risk Verdict. Together they explain what Exported assesses, the scope of its evidence and what a deliverable contains. These notes explain Exported's published PRISM framework and Risk Verdict scope. The questions are a reading guide, not additional research findings or a company-specific assessment. The website's current evidence record and the sample Verdict's dated snapshot remain separate. This is not legal, tax, immigration or investment advice. - [Exported — PRISM's five dimensions](https://exported.io/#system) - [Exported — published evidence and prospective validation](https://exported.io/#evidence) - [Exported — sample Risk Verdict PDF (September 2026)](https://exported.io/sample-risk-verdict.pdf?v=20260930) --- # Is your European technology company ready for US expansion? Source: https://exported.io/insights/eu-tech-us-expansion-readiness/ Public reference updated: 2026-11-12 For a European technology company considering US expansion, Exported's framework examines the buyer, how demand converts to revenue, execution capacity and capital at risk. The scope is not limited to SaaS. Readiness is an evidence-based decision, not a revenue milestone or an incorporation date. ## 1. Specify the US buyer before the market size Start with the segment, problem, budget owner and buying process. A large addressable market does not tell a founder which accounts to pursue or why those accounts would switch from their existing solution. PRISM's GTM-motion dimension asks how demand converts to revenue. Use that question to examine the actual buyer and conversion process, rather than treating the size of the US market as evidence that the expansion motion works. Record disconfirming evidence as carefully as positive feedback. If interviews describe a different problem or buying process from the one in the plan, change the hypothesis before increasing the commitment. - [How PRISM assesses expansion risk](https://exported.io/methodology/) ## 2. Distinguish interest from repeatable conversion Keep introductions, meetings, trials, pilots, signed contracts and collected revenue separate. Each is useful evidence, but each answers a different question. A founder-led sale through a personal relationship does not by itself establish a scalable acquisition channel. For each serious opportunity, document how the buyer arrived, which objections appeared, who approved the purchase, what the sales process required and whether the economics could work beyond that single account. - What did the customer pay for, and why now? - Which conditions were exceptional: discounts, founder access, custom work or a warm introduction? - Could another account in the same segment buy through substantially the same process? ## 3. Map the operating model beyond the first sale List the people and systems required for discovery, sales, procurement, onboarding, implementation, support and renewal. Put an owner against each stage, including what happens outside European working hours. Do not assume the same team can absorb every new requirement without slowing the existing business. Test where founder involvement is necessary and where the plan depends on a hire or partner who is not yet in place. PRISM's execution dimension asks whether infrastructure can carry the motion. A structural assessment does not replace qualified advice on entity structure, employment or tax. - [How PRISM assesses expansion risk](https://exported.io/methodology/) ## 4. Make the capital decision conditional Build a base case and a downside case that connect revenue timing to the actual spending plan. Include sales capacity, implementation effort, support, travel and the resources needed to protect the home-market business. Set evidence gates before committing the next tranche of resources. The useful question is not simply 'Do we have enough runway?' but 'What will we know before the next difficult-to-reverse decision?' A gate should name the evidence, the owner, the decision date and the action if the evidence is absent. The numbers must come from the company's economics; there is no universal budget or runway threshold in this guide. ## 5. Choose a test, a commitment or a pause In Exported's framework, an unresolved assumption is a reason to design a test, not to label the entire company unready. A limited experiment may be appropriate before a local team, office or broader expansion budget. Summarize the decision in one page: target buyer, evidence observed, assumptions remaining, next experiment, budget exposure and stop conditions. Revisit it when the evidence changes rather than treating the initial plan as fixed. - [Structural risks before committing US-expansion capital](https://exported.io/insights/us-expansion-structural-risks/) - [US expansion for founders](https://exported.io/us-expansion-for-founders/) - [The Risk Verdict: scope, pricing and sample](https://exported.io/risk-verdict/) ## Do you need a US entity before testing demand? This guide does not prescribe an entity setup or say that sales can legally proceed without one. The relevant requirements depend on your activities and circumstances. Discuss the legal and tax position with qualified advisers while keeping the commercial demand test a separate decision. Should a founder relocate first? There is no universal sequence. Identify which activities require local presence and which assumption relocation would help test before making a personal and operational commitment. ## Exported's framework and source material These notes explain Exported's published PRISM framework and Risk Verdict scope. The questions are a reading guide, not additional research findings or a company-specific assessment. The website's current evidence record and the sample Verdict's dated snapshot remain separate. This is not legal, tax, immigration or investment advice. - [Exported — PRISM's five dimensions](https://exported.io/#system) - [Exported — published evidence and prospective validation](https://exported.io/#evidence) - [Exported — sample Risk Verdict PDF (September 2026)](https://exported.io/sample-risk-verdict.pdf?v=20260930) --- # Structural risks before committing US-expansion capital Source: https://exported.io/insights/us-expansion-structural-risks/ Public reference updated: 2026-11-12 Structural US-expansion risk is the risk that the expansion configuration cannot turn demand into sustainable revenue within the company's resources. For European technology companies, Exported examines five dimensions: timing, trigger, go-to-market motion, execution and signal misread. ## What makes a risk structural? An isolated sales loss may be a deal-level issue. A repeated mismatch between the buyer, the sales motion and the operating model raises a different question: can the configuration work even if the team executes the current plan? Exported uses 'structural' to focus attention on that configuration. It is an analytical lens, not a claim that every disappointing expansion has the same cause. ## Timing: capital can run ahead of evidence A team may have a plausible target segment but a spending plan that assumes revenue too early. Map the buying process and the delivery work to cash needs instead of treating the launch date as the start of predictable conversion. Compare the cost of a slower sales cycle with the funds available for the existing business and the expansion. A useful downside case changes both revenue timing and the operating effort required to win and support customers. ## Trigger: why expand now? Write down the actual trigger: customer demand, a strategic account, management ambition, investor expectations or another reason. The trigger is not the same as proof that the expansion motion is ready. Ask what evidence would support the decision if that pressure disappeared. This helps separate a commercial opportunity from a timetable imposed by a funding or board narrative. ## GTM motion: the route to revenue must fit the buyer A European company's existing acquisition method may need testing with US buyers. Document who initiates a purchase, which teams evaluate it and what procurement, security or implementation steps the company must support. The published PRISM question is how demand converts to revenue. An active pipeline does not, on its own, answer whether the current motion can convert. - [How PRISM assesses expansion risk](https://exported.io/methodology/) ## Execution: dependencies make commitments harder to reverse A local hire may depend on founder support, implementation capacity, specialist advice and a pipeline of suitable customers. Examine those dependencies together rather than approving each cost in isolation. Exported's problem statement describes the cost of discovering misalignment after capital and hiring are already committed. The execution dimension asks whether infrastructure can carry the motion before correction requires unwinding multiple systems. - [Exported — the structural expansion problem](https://exported.io/#problem) ## Signal misread: activity is not always conversion evidence An enthusiastic meeting, a large pipeline number and a pilot each describe activity at a different stage. Ask what would need to happen next for that signal to become a paying, supportable and repeatable customer relationship. Track the movement between stages and the reasons opportunities stop. The aim is not to disregard early interest, but to avoid giving it more evidential weight than it can carry. ## Turn the risk review into a decision For each dimension, record the assumption, evidence for and against it, capital exposed and the cheapest useful test. Assign an owner and define what would change the plan. This checklist is not a PRISM score or an automated diagnosis. A company-specific Risk Verdict is a separate assessment with its own scope and limitations. - [How PRISM assesses expansion risk](https://exported.io/methodology/) - [Is your European technology company ready for US expansion?](https://exported.io/insights/eu-tech-us-expansion-readiness/) - [The Risk Verdict: scope, pricing and sample](https://exported.io/risk-verdict/) ## Can a strong European business still face US-expansion risk? Yes. The expansion decision introduces assumptions that home-market performance does not settle, including the US buyer, conversion process, operating demands and capital timing. That is why Exported separates underwriting the company from underwriting the expansion. ## Exported's framework and source material These notes explain Exported's published PRISM framework and Risk Verdict scope. The questions are a reading guide, not additional research findings or a company-specific assessment. The website's current evidence record and the sample Verdict's dated snapshot remain separate. This is not legal, tax, immigration or investment advice. - [Exported — PRISM's five dimensions](https://exported.io/#system) - [Exported — published evidence and prospective validation](https://exported.io/#evidence) - [Exported — sample Risk Verdict PDF (September 2026)](https://exported.io/sample-risk-verdict.pdf?v=20260930) --- # Due diligence on a European tech company's US expansion Source: https://exported.io/insights/us-expansion-due-diligence/ Public reference updated: 2026-11-12 US-expansion due diligence should test the expansion thesis separately from the company's overall quality. Review the US buyer evidence, go-to-market assumptions, operating dependencies, downside capital exposure and decision gates. Founders can use the same questions before presenting an expansion budget to their board. ## 1. State the thesis in a form that can be tested Replace 'the US is our next growth market' with a specific statement about the buyer, the problem, the acquisition route and the operating model. Then identify the evidence needed for that statement to remain credible. Separate facts already observed from forecasts and management judgments. A credible company can still have a lightly evidenced expansion hypothesis; diligence should make that distinction explicit rather than conceal it inside an aggregate growth forecast. ## 2. Inspect the quality of demand evidence Review opportunities by stage, origin and buying context. Ask which are paid, which depend on exceptional conditions and which have progressed through the approval process expected of future target accounts. PRISM's signal-misread dimension examines where traction is mistaken for conversion. Read the expansion thesis through that distinction: what shows activity, and what shows the motion converting to revenue? - Identify the budget owner and the operational user. - Distinguish contracted revenue from pipeline and pilots. - Check discounts, bespoke delivery and founder relationship effects. - Record losses and stalled opportunities, not just reference wins. - [How PRISM assesses expansion risk](https://exported.io/methodology/) ## 3. Trace the path from sale to delivery The plan should account for procurement, onboarding, implementation, support and renewal, not just lead generation and sales hiring. Map dependencies across the European and US teams and identify responsibilities that are currently unowned. PRISM's execution dimension asks whether infrastructure can carry the motion. The Risk Verdict addresses structural risk; legal, tax and employment decisions remain outside that assessment. - [The Risk Verdict: scope, pricing and sample](https://exported.io/risk-verdict/) ## 4. Connect the downside to capital exposure Test what changes if the sales cycle is longer, conversion weaker or delivery more resource-intensive than planned. Identify which costs can be paused and which would be difficult to unwind without harming the company. Do not treat a revised revenue forecast as a complete downside model. Review the operating consequences, founder attention and funding needs of maintaining both the home market and the expansion during that delay. ## 5. Define decision gates before the commitment An approval can be conditional. Specify the evidence required before adding headcount, increasing acquisition spend or making another difficult-to-reverse commitment. Each gate needs an accountable owner, a review date and an action if the evidence is absent. Founders and investors should agree what would justify continuing, changing the motion or pausing before the pressure of a missed target arrives. ## 6. Read model claims within their actual scope If using an external assessment, ask what population each metric describes, when the evaluation took place and what remains uncertain. Case-log size, model-training samples, cross-validation metrics and prospectively verified outcomes are not interchangeable. Exported publishes a scoped evidence record and a PRISM methodology explanation. A sample Risk Verdict is a dated deliverable, not a substitute for a company-specific assessment or the current validation record. - [How PRISM assesses expansion risk](https://exported.io/methodology/) - [Read Exported's original evidence record](https://exported.io/#evidence) ## Is expansion diligence only for venture-capital teams? No. Founders and boards can use this review before allocating an expansion budget, whether or not a financing round is involved. The core question is which evidence justifies the next commitment and what happens if the thesis is wrong. Does a risk assessment replace investment judgment? No. It is one input alongside financial, legal, technical and other diligence; it does not establish a valuation or guarantee returns. - [US expansion for investors](https://exported.io/us-expansion-for-investors/) - [US expansion for founders](https://exported.io/us-expansion-for-founders/) - [The Risk Verdict: scope, pricing and sample](https://exported.io/risk-verdict/) ## Exported's framework and source material These notes explain Exported's published PRISM framework and Risk Verdict scope. The questions are a reading guide, not additional research findings or a company-specific assessment. The website's current evidence record and the sample Verdict's dated snapshot remain separate. This is not legal, tax, immigration or investment advice. - [Exported — PRISM's five dimensions](https://exported.io/#system) - [Exported — published evidence and prospective validation](https://exported.io/#evidence) - [Exported — sample Risk Verdict PDF (September 2026)](https://exported.io/sample-risk-verdict.pdf?v=20260930)